In silico multiscale drug design to discover key structural features of potential JAK2 inhibitors.
Sign Up to like & getrecommendations! Published in 2022 at "Future medicinal chemistry"
DOI: 10.4155/fmc-2022-0124
Abstract: Background: JAK2 inhibitors have been proposed as a new therapeutic option for thalassemia therapy. The objective of this study was to discover the key structural features for improving 2-aminopyrimidine derivatives as potential JAK2 inhibitors. Materials… read more here.
Keywords: key structural; jak2 inhibitors; discover key; jak2 ... See more keywords